Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh, Jim McMenamin, J. R. Taylor, et al.
The Lancet (2021) Vol. 397, Iss. 10293, pp. 2461-2462
Open Access | Times Cited: 997

Showing 51-75 of 997 citing articles:

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Charlotte Gower, Nick Andrews
New England Journal of Medicine (2021) Vol. 385, Iss. 25, pp. e92-e92
Open Access | Times Cited: 167
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 166
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 158
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Effectiveness of mRNA and ChAdOx1 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
Sharifa Nasreen, Hannah Chung, Siyi He, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 147
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141
Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021
David A. Siegel, Hannah E. Reses, Andrea J. Cool, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 36, pp. 1249-1254
Open Access | Times Cited: 140
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e715-e725
Open Access | Times Cited: 140
Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France
Rebecca Grant, Tiffany Charmet, Laura Schaeffer, et al.
The Lancet Regional Health - Europe (2021) Vol. 13, pp. 100278-100278
Open Access | Times Cited: 137
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
Thomas Harder, Wiebe Külper-Schiek, Sarah Reda, et al.
Eurosurveillance (2021) Vol. 26, Iss. 41
Open Access | Times Cited: 136
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Environmental Factors Influencing COVID-19 Incidence and Severity
Amanda Weaver, Jennifer R. Head, Carlos Gould, et al.
Annual Review of Public Health (2022) Vol. 43, Iss. 1, pp. 271-291
Open Access | Times Cited: 131
Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative
Blake Martin, Peter DeWitt, Seth Russell, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2143151-e2143151
Open Access | Times Cited: 130
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
Emma Wall, Mary Wu, Ruth Harvey, et al.
The Lancet (2021) Vol. 398, Iss. 10296, pp. 207-209
Open Access | Times Cited: 128
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Lindsey Wang, QuanQiu Wang, Pamela B. Davis, et al.
World Psychiatry (2021) Vol. 21, Iss. 1, pp. 124-132
Open Access | Times Cited: 124
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021
Jennifer Griffin, Meredith Haddix, Phoebe Danza, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 34, pp. 1170-1176
Open Access | Times Cited: 119
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Eurosurveillance (2021) Vol. 26, Iss. 28
Open Access | Times Cited: 116
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 109
COVID-19 in patients with hematologic malignancy
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 108
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021)
Open Access | Times Cited: 107
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
Miloslav Klugar, Abanoub Riad, Lekshmi Mohanan, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1437-1437
Open Access | Times Cited: 106

Scroll to top